Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 89 | NANETS2022 | Next issue

NANETS 2022

15th Annual Multidisciplinary NET Medical Symposium NANETS 2022

Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Previous section
Clinical – Chemo/SSA/Biologics
Table of contents
Next section
Clinical – Surgery/Applied Pathology

ea0089c14 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT

ea0089c15 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Effectiveness and Safety of Re-Treatment With 177Lu-DOTATATE in Patients With Progressive NETs in the US: a Retrospective Real-World Study

ea0089c16 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Clinical Utility of Somatostatin Receptor Positron Emission Tomography Imaging Biomarkers for Characterization of Meningioma Among Incidental Central Nervous System Lesions

ea0089c17 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Integration of Radioembolization with CapTem for Liver-Dominant G2 NETs: Long-Term Outcomes

ea0089c18 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Radiosensitization for TARE: Does Duration of Chemotherapy Affect PFS?List of participants and their roles in the submission

ea0089c19 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Transformation of G1-G2 Neuroendocrine Tumors (NETs) to Neuroendocrine Carcinomas (NECs) Following Peptide Receptor Radionuclide Therapy (PRRT): a Case Series

ea0089c20 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Quality of Life Assessments for Advanced Pheochromocytoma and Paraganglioma Patients that Received High-Specific-Activity I-131 MIBG: Results from a Pivotal Phase 2 Clinical Trial

ea0089c21 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Characterizing Bone Metastases in Patients with Well-Differentiated Neuroendocrine Neoplasms Utilizing Ga68-DOTATATE PET

ea0089c22 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

The Role of 68Ga-DOTATATE PET/CT in the Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors

ea0089c23 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Somatostatin receptor expression in lung neuroendocrine tumors: an analysis of Dotatate PET scans

ea0089c24 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

MIBG and DOTATATE Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience

ea0089c25 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Evaluation of 68Ga-DOTATATE PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)

ea0089c26 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Pre-therapy Functional Imaging with MIBG and DOTATATE to Guide Radiopharmaceutical Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience

ea0089c27 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, CT, and MRI Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma/Paraganglioma

ea0089c28 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI in the Detection of MEN2A-related-pheochromocytoma

ea0089c29 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging

Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI the Detection of VHL-related Pheochromocytoma

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more